|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Type 2 diabetes, glucose homeostasis and incident atrial fibrillation:the Atherosclerosis Risk in Communities study显示文摘 | Huxley RR Alonso A Lopez FL | 2012 | Heart2012，98，2： | 1 |
| 2 | Blood lipid levels, lipid lowering medications, and the Incidence of atrial fibrillation : the ather-osclerosis risk in communities (ARIC) study显示文摘 | Lopez FL Agarwal SK MacLehose RF | 2012 | Circ Arrhythm Elec- trophysiol2012，5，1： | 1 |
| 3 | Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2 显示文摘 | TURDI S LI Q LOPEZ FL | 2007 | Life Sci2007，81，11： | 1 |
| 4 | The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘 | International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M | 2010 | Science2010，330，6010： | 1 |
| 5 | Usefulness of high-sensitiv- ity C-reactive protein to predict mortality in patients with atrial fibril- lation ( from the Atherosclerosis Risk In Communities Study 显示文摘 | Hermida J Lopez FL Montes R | 2012 | Am J Cardiol2012，109，1： | 1 |
| 6 | Usefulness ofHigh-Sensitivity C-Reactive protein to predict mortalityin patients with atrial fibrillation (from theatherosclerosis risk in communities study) 显示文摘 | Hermida J Lopez FL Montes R | 2012 | Am J Cardiol2012，109，1： | 1 |
| 7 | Usefulness of high- sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities Study) 显示文摘 | Hermida J Lopez FL Montes R | 2012 | Am J Cardiol2012，109，1： | 1 |
| 8 | Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors:The Atherosclerosis Risk In Communities (ARIC) study显示文摘 | Huxley RR Lopez FL Folsom AR | 2011 | Circulation2011，123，： | 1 |
| 9 | Serum transferrin receptor in children:usefulness for determinating the nature of anemia in infection显示文摘 | Angeles Vazquez Lopez M Molonis FL Carmona ML | 2006 | Pediatr Hematol Oncol2006，28，12： | 1 |
| 10 | Study of load capacity of Avicel PH-200 and Cellactose,two direct compression excipients,using experimental design显示文摘 | Estrada FL Lopez AR Diaz EJJ | 2000 | Drug Dev lnd Pharm2000，26，4： | 1 |
| 11 | Absolute and attributable risks of at- rial fibrillation in relation to optimal and borderline risk factors: the Atheroscle- rosis Risk in Communities ( ARIC ) study 显示文摘 | Huxley RR Lopez FL Folsom AR | 2011 | Circulation2011，123，： | 1 |
| 12 | Blood lipid levels,lipid-lowering medications,and the incidence of atrial fibrillation:the atherosclerosis risk in communities study显示文摘 | Lopez FL Agarwal SK Maclehose RF | | 0，，01： | 1 |
| 13 | Type 2 diabetes, glu- cose homeostasis and incident atrial fibrillation: the Atheroscle- rosis Risk in Communities study显示文摘 | Huxley RR Alonso A Lopez FL | 2012 | Heart2012，98，2： | 1 |
| 14 | Blood lipid levels,lipid-lowering medications,and the incidence of atrial fibrillationL the atherosclerosis risk in communities study显示文摘 | Lopez FL Agarwal SK Maclehous RF | | 0，，01： | 1 |
| 15 | Catalase alleviates cardiomyocyte dysfunction in diabetes:role of Akt,Forkhead transcriptional factor and silent information regulator 2显示文摘 | Turdi S Li Q Lopez FL | 2007 | Life Sci2007，81，11： | 1 |
| 16 | HMS mesoporous silica as cobalt support for the Fischer-Tropsch synthesis:Pretreatment,cobalt loading and particle size effects显示文摘 | LIRA E LOPEZ CM OROPEZA F BARTOLINI M ALVAREZ J GOLDWASSER M LINARES FL LAMONIER J F ZURITA M J P | 2008 | J Mol Catal A:Chem2008，281，12： | 1 |
| 17 | Chronic kidney disease is associated with the incidence of atrial fibrillation:the Atherosclerosis Risk in Communities (ARIC) study 显示文摘 | Alonso A Lopez FL Matsushita K | 2011 | Circulation2011，123，： | 1 |
| 18 | Chronic kidney disease is associated with the incidence of atrial fibrillation:the Atherosclerosis Risk in Communities(ARIC)study显示文摘 | Alonso A Lopez FL Matsushita K | 2011 | Circulation2011，123，25： | 1 |
| 19 | Usefulness of high- sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities Study)显示文摘 | Hermida J Lopez FL Montes R | 2012 | Am J Cardiol2012，109，1： | 1 |
| 20 | Chronic kidney disease is associated with the incidence of atrial fibrillation: the Athero- sclerosis Risk in Communities (ARIC) Study 显示文摘 | Alonso A Lopez FL Matsushita K | 2011 | Circulation2011，123，25： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员